Statins for the treatment of COVID-19 patients: an updated meta-analysis of randomized controlled trials

被引：0
|
作者：
Fatemeh Movahed [1 ]
Ehsan Heidari [3 ]
Masoud Dehbozorgi [1 ]
Saba Goodarzi [2 ]
Fatemeh Esmaeilpur Abianeh [4 ]
Mohammad Abbasi [3 ]
Aida Rezaei Nejad [4 ]
Mohammad Javad Amini [3 ]
Mahmood Bakhtiyari [4 ]
Mojtaba Hedayat Yaghoubi [5 ]
Arman Shafiee [5 ]
机构：
[1] Shahid Beheshti University of Medical Sciences,Student Research Committee, School of Medicine
[2] The Faculty of Medicine,School of Medicine
[3] RWTH Aachen University,undefined
[4] Rheinisch-Westfälische Technische,undefined
[5] Hochschule Aachen,undefined
[6] Tehran University of Medical Science,undefined
[7] Alborz University of Medical Sciences,undefined
[8] Alborz University of Medical Sciences,undefined
来源：
Discover Medicine | / 1卷 / 1期
关键词：
Hydroxymethylglutaryl-CoA Reductase Inhibitors; Covid-19; Treatment;
D O I：
10.1007/s44337-024-00092-w
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
    Chia Siang Kow
    Syed Shahzad Hasan
    European Journal of Clinical Pharmacology, 2021, 77 : 1089 - 1094
  • [22] Role of colchicine in the management of COVID-19 patients: A meta-analysis of cohort and randomized controlled trials
    Singh, Avinash Kumar
    Vidyadhari, Arya
    Singh, Harmandeep
    Haider, Kashif
    Kumar, Anoop
    Sharma, Manju
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2022, 16
  • [23] Remdesivir therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
    Vegivinti, Charan Thej Reddy
    Pederson, John M.
    Saravu, Kavitha
    Gupta, Nitin
    Barrett, Averi
    Davis, Amber R.
    Kallmes, Kevin M.
    Evanson, Kirk W.
    ANNALS OF MEDICINE AND SURGERY, 2021, 62 : 43 - 48
  • [24] Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
    Lan, Shao-Huan
    Wang, Chiung-Kai
    Chang, Shen-Peng
    Lu, Li-Chin
    Hung, Shun-Hsing
    Lin, Wei-Ting
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (05) : 773 - 780
  • [25] The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
    Kow, Chia Siang
    Hasan, Syed Shahzad
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (08) : 1089 - 1094
  • [26] Statins for the prevention and treatment of stroke: A meta-analysis of randomized controlled trials
    Berwanger, O
    Avezum, A
    Fernandes, J
    Guimaraes, HP
    Bertolami, M
    Marx, CB
    da Silva, NB
    Piegas, L
    STROKE, 2006, 37 (02) : 664 - 664
  • [27] Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Muhammad Ehsan
    Uzair Jafar
    Momina Butt
    Aiman Naveed
    Mohammad Umer
    Muhammad Ayyan
    Biah Mustafa
    Rehmat Ullah Awan
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 495 - 498
  • [28] Tocilizumab for COVID-19: A systematic review and meta-analysis of randomized controlled trials
    Boppana, Tarun Krishna
    Mittal, Saurabh
    Madan, Karan
    Mohan, Anant
    Hadda, Vijay
    Guleria, Randeep
    MONALDI ARCHIVES FOR CHEST DISEASE, 2022, 92 (04)
  • [29] Role of Thromboprophylaxis in Outpatients With COVID-19: A Meta-Analysis of Randomized Controlled Trials
    Singh, Sahib
    Tantry, Udaya
    Bliden, Kevin
    Garg, Aakash
    Gurbel, Paul
    CIRCULATION, 2023, 148
  • [30] Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Ehsan, Muhammad
    Jafar, Uzair
    Butt, Momina
    Naveed, Aiman
    Umer, Mohammad
    Ayyan, Muhammad
    Mustafa, Biah
    Awan, Rehmat Ullah
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (03) : 495 - 498
12345